TY - JOUR A1 - Braune, Steffen A1 - Gross, M. A1 - Walter, M. A1 - Zhou, Shengqiang A1 - Dietze, Siegfried A1 - Rutschow, S. A1 - Lendlein, Andreas A1 - Tschoepe, C. A1 - Jung, Friedrich T1 - Adhesion and activation of platelets from subjects with coronary artery disease and apparently healthy individuals on biomaterials JF - Journal of biomedical materials research : an official journal of the Society for Biomaterials, the Japanese Society for Biomaterials; the Australian Society for Biomaterials N2 - On the basis of the clinical studies in patients with coronary artery disease (CAD) presenting an increased percentage of activated platelets, we hypothesized that hemocompatibility testing utilizing platelets from healthy individuals may result in an underestimation of the materials' thrombogenicity. Therefore, we investigated the interaction of polymer-based biomaterials with platelets from CAD patients in comparison to platelets from apparently healthy individuals. In vitro static thrombogenicity tests revealed that adherent platelet densities and total platelet covered areas were significantly increased for the low (polydimethylsiloxane, PDMS) and medium (Collagen) thrombogenic surfaces in the CAD group compared to the healthy subjects group. The area per single platelet—indicating the spreading and activation of the platelets—was markedly increased on PDMS treated with PRP from CAD subjects. This could not be observed for collagen or polytetrafluoroethylene (PTFE). For the latter material, platelet adhesion and surface coverage did not differ between the two groups. Irrespective of the substrate, the variability of these parameters was increased for CAD patients compared to healthy subjects. This indicates a higher reactivity of platelets from CAD patients compared to the healthy individuals. Our results revealed, for the first time, that utilizing platelets from apparently healthy donors bears the risk of underestimating the thrombogenicity of polymer-based biomaterials. KW - platelets KW - biomaterials KW - hemocompatibility KW - cardiovascular disease KW - cardiovascular implant Y1 - 2016 U6 - https://doi.org/10.1002/jbm.b.33366 SN - 1552-4973 SN - 1552-4981 VL - 104 SP - 210 EP - 217 PB - Wiley-Blackwell CY - Hoboken ER - TY - JOUR A1 - Lau, Skadi A1 - Maier, Anna A1 - Braune, Steffen A1 - Gossen, Manfred A1 - Lendlein, Andreas T1 - Effect of endothelial culture medium composition on platelet responses to polymeric biomaterials JF - International journal of molecular sciences N2 - Near-physiological in vitro thrombogenicity test systems for the evaluation of blood-contacting endothelialized biomaterials requires co-cultivation with platelets (PLT). However, the addition of PLT has led to unphysiological endothelial cell (EC) detachment in such in vitro systems. A possible cause for this phenomenon may be PLT activation triggered by the applied endothelial cell medium, which typically consists of basal medium (BM) and nine different supplements. To verify this hypothesis, the influence of BM and its supplements was systematically analyzed regarding PLT responses. For this, human platelet rich plasma (PRP) was mixed with BM, BM containing one of nine supplements, or with BM containing all supplements together. PLT adherence analysis was carried out in six-channel slides with plasma-treated cyclic olefin copolymer (COC) and poly(tetrafluoro ethylene) (PTFE, as a positive control) substrates as part of the six-channel slides in the absence of EC and under static conditions. PLT activation and aggregation were analyzed using light transmission aggregometry and flow cytometry (CD62P). Medium supplements had no effect on PLT activation and aggregation. In contrast, supplements differentially affected PLT adherence, however, in a polymer- and donor-dependent manner. Thus, the use of standard endothelial growth medium (BM + all supplements) maintains functionality of PLT under EC compatible conditions without masking the differences of PLT adherence on different polymeric substrates. These findings are important prerequisites for the establishment of a near-physiological in vitro thrombogenicity test system assessing polymer-based cardiovascular implant materials in contact with EC and PLT. KW - cyclic olefin copolymer KW - poly(tetrafluoroethylene) KW - endothelial cells KW - platelets KW - in vitro thrombogenicity testing Y1 - 2021 U6 - https://doi.org/10.3390/ijms22137006 SN - 1422-0067 SN - 1661-6596 VL - 22 IS - 13 PB - Molecular Diversity Preservation International CY - Basel ER -